Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Som D Mukherjee

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of the National Cancer Institute|March 6, 2015
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32Pamela J Goodwin, Wendy R Parulekar, Karen A Gelmon, et al.
The Journal of Urology|January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC SubstudyJehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
JAMA|May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical TrialPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
The Lancet. Oncology|September 24, 2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trialThomas Powles, Michiel S van der Heijden, Daniel Castellano, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of the National Cancer Institute|March 6, 2015
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32Pamela J Goodwin, Wendy R Parulekar, Karen A Gelmon, et al.
The Journal of Urology|January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC SubstudyJehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
JAMA|May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical TrialPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
The Lancet. Oncology|September 24, 2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trialThomas Powles, Michiel S van der Heijden, Daniel Castellano, et al.
The New England Journal of Medicine|December 12, 2012
Abiraterone in metastatic prostate cancer without previous chemotherapyCharles J Ryan, Matthew R Smith, Johann S de Bono, et al.
Pageof 6